LAURUSLABS.NS Profit & Loss
Laurus Labs Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:35
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Revenue from Operations | ₹6,040.55 Cr. | ₹5,040.83 Cr. | ₹5,553.96 Cr. | ₹6,812.90 Cr. | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | N/A | N/A | SegmentRevenueFromOperations |
| Other Income | ₹6.00 Cr. | ₹26.34 Cr. | ₹75.10 Cr. | ₹54.95 Cr. | OtherIncome |
| Total Income | ₹6,046.55 Cr. | ₹5,067.17 Cr. | ₹5,629.06 Cr. | ₹6,867.85 Cr. | Income |
| Cost of Materials Consumed | ₹2,596.57 Cr. | ₹2,422.38 Cr. | ₹2,428.55 Cr. | ₹2,794.34 Cr. | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹155.71 Cr. | ₹110.92 Cr. | ₹105.36 Cr. | ₹172.56 Cr. | PurchasesOfStockInTrade |
| Changes in Inventories | ₹22.04 Cr. | ₹-100.88 Cr. | ₹-55.93 Cr. | ₹-271.44 Cr. | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹580.64 Cr. | ₹639.93 Cr. | ₹719.52 Cr. | ₹895.45 Cr. | EmployeeBenefitExpense |
| Finance Costs | ₹165.17 Cr. | ₹182.90 Cr. | ₹216.00 Cr. | ₹170.73 Cr. | FinanceCosts |
| Depreciation and Amortisation | ₹324.08 Cr. | ₹384.58 Cr. | ₹430.09 Cr. | ₹480.05 Cr. | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹1,093.40 Cr. | ₹1,190.98 Cr. | ₹1,301.18 Cr. | ₹1,444.28 Cr. | OtherExpenses |
| Total Expenses | ₹4,937.61 Cr. | ₹4,830.81 Cr. | ₹5,144.77 Cr. | ₹5,685.97 Cr. | Expenses |
| Profit Before Exceptional Items and Tax | ₹1,108.94 Cr. | ₹236.36 Cr. | ₹484.29 Cr. | ₹1,181.88 Cr. | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹1,108.94 Cr. | ₹236.36 Cr. | ₹484.29 Cr. | ₹1,181.88 Cr. | ProfitBeforeTax |
| Tax Expense | ₹312.30 Cr. | ₹68.15 Cr. | ₹129.88 Cr. | ₹292.03 Cr. | TaxExpense |
| Net Profit (incl. minority interest) | ₹793.43 Cr. | ₹162.27 Cr. | ₹358.34 Cr. | ₹890.14 Cr. | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹790.11 Cr. | ₹160.55 Cr. | ₹358.32 Cr. | ₹888.79 Cr. | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹14.69 | ₹2.98 | ₹6.65 | ₹16.47 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹14.64 | ₹2.97 | ₹6.64 | ₹16.45 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from LAURUSLABS.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).